BioSpace News Archive

Science Exchange, the leading marketplace for outsourced R&D™, announced today that it has become a Corporate Partner of One Nucleus, the membership organization for life science and healthcare companies.

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of industry leader David Gollaher, Ph.D., to the company’s Board of Directors.

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share

Targeted Oncology™, a print and digital resource that offers content and expert opinions on precision medicine in oncology, will launch its second “Expert Perspective: Virtual Tumor Board” on Wednesday, September 12.

Novartis today announced that The New England Journal of Medicine (NEJM) has published full results from the landmark Phase III Gilenya® (fingolimod) PARADIGMS study,

Surefire Medical, Inc., (Surefire) announced today the company is changing its name to TriSalus Life Sciences to better reflect the company’s contribution to patient care.

CVD Equipment Corporation (NASDAQ: CVV), a leading provider of chemical vapor deposition systems, today announced that its Board of Directors has established the new position of Lead Independent Director and the Company’s independent directors unanimously elected Lawrence J. Waldman to the newly created position.

BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced the appointment of David S. Tierney, M.D., as its chief executive officer.

Aya Healthcare announced its partnership with Health Scholars today.

Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of OPKO Health, Inc.